Benefitfocus Announces Second Quarter 2022 Financial Results 

Rhea-AI Summary

Benefitfocus (NASDAQ: BNFT) reported its Q2 2022 results with revenue of $56.6 million, aligning with guidance expectations. GAAP net loss decreased to ($13.8 million), with a GAAP EPS of ($0.40). Notable developments included the launch of Claims Audit & Recovery Services and a strategic partnership with Lockton to expand in the employer segment. For Q3 2022, revenue guidance remains at $55 million to $57 million, while full-year revenue forecast is $252 million to $258 million.

Positive

• Revenue of $56.6 million met guidance expectations.
• Adjusted EBITDA of $6.2 million exceeded guidance range.
• Partnership with Lockton expected to enhance market penetration.

Negative

• Revenue declined approximately 7% year-over-year.
• Professional services revenue dropped by 25% compared to Q2 2021.
• Free cash flow was negative at ($2.1 million).

Delivered on Second Quarter Financial Commitments

Executing on Transformational Plan to Return to Sustainable Growth

CHARLESTON, S.C., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), an industry-leading cloud-based benefits administration technology company that simplifies benefits administration for employers, health plans and brokers, today announces its second quarter 2022 financial results:  

Financial Highlights for the Second Quarter 2022:

• Revenue of $56.6 million was at the high end of the guidance range of $55 to $57 million.
• Adjusted EBITDA of $6.2 million was above the high end of the guidance range of $4 to $6 million.
• GAAP net loss available to common stockholders was ($13.8) million, compared to ($16.6) million in the second quarter of 2021.  
• GAAP EPS was ($0.40) in the second quarter of 2022 and non-GAAP EPS was ($0.10).  

Operational Highlights for the Second Quarter 2022:

• Launched a new product called Claims Audit & Recovery Services, which is designed to analyze claims data to identify errors and waste, and seek reimbursement.
• Entered into a strategic sales partnership with Lockton, expected to drive further penetration into the employer segment.
• Appointed Ed Rumzis as our new Chief Technology Officer starting on August 8, adding another seasoned industry veteran to the leadership team.
  

“During the second quarter, the team continued to demonstrate a high say:do ratio against our three-pillar transformation plan.” said Benefitfocus President and Chief Executive Officer, Matt Levin. “We are establishing relationships with key players in the ecosystem and seeing early indicators that our go-to-market strategy is working, both a testament to our unwavering focus on service excellence.”

“We were once again able to deliver financial results at or better than our guidance ranges for this quarter,” said Alpana Wegner, Chief Financial Officer. “We are pleased with the progress we are making on executing our strategy to drive sustainable growth and are well-positioned to unlock long-term value for our shareholders.”

Second Quarter 2022 Financial Highlights
Revenue

• Total revenue was $56.6 million, down approximately 7% compared to the second quarter of 2021.   
• Software services, which is comprised of both subscription and platform revenue, was $48.6 million, down 3% compared to the second quarter of 2021.
  • Subscription revenue was $42.0 million, down 5% compared to the second quarter of 2021.
  • Platform revenue was $6.6 million, up 12% compared to the second quarter of 2021.
• Professional services revenue was $8.0 million, down 25% compared to the second quarter of 2021.
  

Net Loss

• GAAP net loss was ($12.2) million, compared to ($15.0) million in the second quarter of 2021. GAAP net loss per share was ($0.40), based on ($13.8) million net loss available to common stockholders and 34.0 million basic and diluted weighted average common shares outstanding. This compares to GAAP net loss per share of ($0.50) for the second quarter of 2021, based on ($16.6) million net loss available to common stockholders and 33.1 million basic and diluted weighted average common shares outstanding.
  

Non-GAAP Net Loss, Adjusted EBITDA and Free Cash Flow

• Non-GAAP net loss available to common stockholders was ($3.5) million for the second quarter of 2022, compared to ($5.9) million in the second quarter of 2021. Non-GAAP net loss per share was ($0.10) based on both 34.0 million basic and diluted weighted average common shares outstanding. This compares to non-GAAP net loss of ($0.18) in the second quarter of 2021, based on both 33.1 million basic and diluted weighted average common shares outstanding.
• Adjusted EBITDA was $6.2 million, compared to $9.6 million in the second quarter of 2021.  
• Cash used in operations was ($0.7) million and free cash flow was ($2.1) million, compared to cash from operations of $9.2 million and $6.6 million of free cash flow in the second quarter of 2021.
  

See important disclosures about non-GAAP measures, and a reconciliation of them to GAAP, below.

Balance Sheet
Cash and cash equivalents at June 30, 2022, totaled $51.5 million, compared to cash and cash equivalents and marketable securities of $68.1 million at the end of the of 2021, a decline driven by the timing of working capital changes.

The full $50.0 million line of credit remains available to the company.

Business Outlook
Benefitfocus is providing guidance for the third quarter and full year 2022 as indicated below.

Third Quarter 2022

• Total revenue is expected to be in the range of $55 million to $57 million.
• Adjusted EBITDA is expected to be in the range of $4 million to $6 million.
• Non-GAAP net loss available to common stockholders is expected to be between ($6.0) million and ($4.0) million, or between ($0.18) and ($0.12) per share based on 34.0 million basic and diluted weighted average shares outstanding.
  

Full-Year 2022

• Total revenue is expected to be in the range of $252 million to $258 million.
• Adjusted EBITDA is expected to be in the range of $44 million to $50 million.
• Free cash flow is expected to be in the range of $18 million to $24 million.
  

Adjusted EBITDA and free cash flow guidance excludes the impact of restructuring and impairment charges.

Management has not reconciled forward-looking non-GAAP net loss, adjusted EBITDA or free cash flow to their most directly comparable GAAP measure of GAAP net loss or GAAP operating cash flows. This is because we cannot predict with reasonable certainty the ultimate outcome of the various necessary GAAP components of such reconciliations, including, for example, those related to certain impairment charges, acquisition transactions and integration, costs not core to our business or others that may arise during the year, without unreasonable effort. These components and other factors could materially impact the amount of future directly comparable GAAP measures, which may differ significantly from their non-GAAP counterparts. See below for additional important disclosures regarding our non-GAAP financial measures.

Conference Call Details:
In conjunction with this announcement, Benefitfocus will host a conference call to discuss the company’s financial results and business outlook on Wednesday, August 3, 2022, at 5:00 p.m. ET. To access this call, dial (800) 941-4658 (domestic) or +1 (416) 981-9033 (international). A live webcast of the conference call will be available on the Investor Relations page of the company’s website at http://investor.benefitfocus.com/. After the conference call, a replay will be available until August 10, 2022, at 11:59 p.m. ET and can be accessed by dialing (844) 512-2921 (domestic) or +1 (412) 317-6671 (international) with passcode 22019867.

About Benefitfocus
Benefitfocus (NASDAQ: BNFT) is a cloud-based benefits administration technology company committed to helping our customers, and the people they serve, get the most out of their health care and benefit programs. Through exceptional service and innovative SaaS solutions, we aim to be the safest set of hands for our customers helping to simplify the complexity of benefits administration while delivering an experience that engages people and unlocks the potential for better health and improved outcomes.  Our mission is simple: to improve lives with benefits. 

Non-GAAP Financial Measures
The company uses certain non-GAAP financial measures in this release, including non-GAAP gross profit, operating income/loss, net loss/income, net loss/income per common share, adjusted EBITDA and free cash flow. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance or financial position that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. 

Non-GAAP gross profit, operating income/loss, net loss/income and net loss/income per common share exclude stock-based compensation expenses, amortization of acquisition-related intangible assets, transaction and acquisition-related costs expensed, expense related to the impairment of goodwill, intangible assets and long-lived assets, gain or loss on extinguishment of debt, change in fair value of contingently returnable consideration and costs not core to our business. We define adjusted EBITDA as net loss before net interest, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense; transaction and acquisition-related costs expensed; restructuring costs; impairment of goodwill, intangible assets and long-lived assets; gain or loss on extinguishment of debt; other costs not core to our business; loss on settlement of lawsuits; and, now, changes in fair value of contingently returnable consideration. The revision to our definition of adjusted EBITDA had no impact on our reported adjusted EBITDA in prior periods. We define free cash flow as cash provided by or used in operating activities less capital expenditures, adjusted to eliminate cash paid for restructuring costs. Please note that other companies might define their non-GAAP financial measures differently than we do.

Management presents these non-GAAP financial measures in this release because it considers them to be important supplemental measures of performance. Management uses these non-GAAP financial measures for planning purposes, including analysis of the company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management believes that these non-GAAP financial measures provide additional insight for analysts and investors in evaluating the company's financial and operational performance. Management also intends to provide these non-GAAP financial measures as part of the company’s future earnings discussions and, therefore, their inclusion should provide consistency in the company’s financial reporting.

Non-GAAP financial measures have limitations as an analytical tool. Investors are encouraged to review the reconciliation of the non-GAAP measures to their most directly comparable GAAP measures provided in this release, including in the accompanying tables.

Safe Harbor Statement
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our need to increase sales and achieve consistent GAAP profitability; fluctuations in our financial results; our ability to maintain our culture and recruit, integrate and retain qualified personnel, including on our board of directors; our ability to compete effectively and implement our growth strategy; our reliance on channel relationships; market developments and opportunities; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; the immature and volatile nature of the market for our products and services; privacy; security and other risks associated with our business; management of growth; volatility and uncertainty in the global economy and financial markets in light of the evolving COVID-19 pandemic and war in Ukraine; and the other risk factors set forth from time to time in our SEC filings, copies of which are available free of charge within the Investor Relations section of the Benefitfocus website at http://investor.benefitfocus.com/sec-filings or upon request from our Investor Relations Department. Benefitfocus assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Source: Benefitfocus, Inc.

Media Contact:
843-981-8898
pr@benefitfocus.com 

Investor Relations:
Doug Kuckelman
843-790-7460
ir@benefitfocus.com 

Benefitfocus, Inc. Unaudited Consolidated Statements of Operations and Comprehensive Loss (in thousands, except share and per share data)
		Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021
Revenue		$	56,587			$	60,904			$	117,812			$	125,967
Cost of revenue(1)(2)			29,095				28,030				58,981				56,623
Gross profit			27,492				32,874				58,831				69,344
Operating expenses:(1)(2)(3)
Sales and marketing			10,643				10,921				20,567				21,812
Research and development			12,249				11,103				23,406				21,935
General and administrative			13,517				13,571				22,806				23,433
Impairment of lease right-of-use assets			1,769				4,003				1,769				4,003
Change in fair value of contingently returnable consideration			(719	)			–				(719	)			–
Restructuring costs			–				2,727				1,006				4,127
Total operating expenses			37,459				42,325				68,835				75,310
Loss from operations			(9,967	)			(9,451	)			(10,004	)			(5,966	)
Other income (expense):
Interest income			72				54				84				111
Interest expense			(2,476	)			(5,646	)			(4,958	)			(11,201	)
Other income			236				64				482				22
Total other expense, net			(2,168	)			(5,528	)			(4,392	)			(11,068	)
Loss before income taxes			(12,135	)			(14,979	)			(14,396	)			(17,034	)
Income tax expense			29				41				45				83
Net loss			(12,164	)			(15,020	)			(14,441	)			(17,117	)
Preferred dividends			(1,600	)			(1,600	)			(3,200	)			(3,200	)
Net loss available to common stockholders		$	(13,764	)		$	(16,620	)		$	(17,641	)		$	(20,317	)
Comprehensive loss		$	(12,164	)		$	(15,020	)		$	(14,441	)		$	(17,117	)
Net loss per common share:
Basic and diluted		$	(0.40	)		$	(0.50	)		$	(0.52	)		$	(0.62	)
Weighted-average common shares outstanding:
Basic and diluted			34,028,422				33,080,257				33,764,103				32,787,162
(1) Stock-based compensation included in above line items:
Cost of revenue		$	1,008			$	638			$	1,204			$	964
Sales and marketing			1,110				927				1,746				1,507
Research and development			783				503				1,014				621
General and administrative			2,414				2,308				2,540				2,807
(2) Amortization of acquired intangible assets included in above line items:
Cost of revenue		$	610			$	336			$	1,232			$	673
Sales and marketing			131				77				273				153
Research and development			233				113				449				226
General and administrative			99				43				192				85
(3) Transaction and acquisition-related costs expensed included in above line items:
General and administrative		$	13			$	6			$	96			$	160

Benefitfocus, Inc. Unaudited Consolidated Balance Sheets (in thousands, except share and per share data)
		As of June 30, 2022				As of December 31, 2021
Assets
Current assets:
Cash and cash equivalents		$	51,497			$	31,001
Marketable securities			–				37,049
Accounts receivable, net			22,342				16,491
Contract, prepaid and other current assets			33,558				27,615
Total current assets			107,397				112,156
Property and equipment, net			26,048				27,202
Financing lease right-of-use assets			50,391				56,474
Operating lease right-of-use assets			669				774
Intangible assets, net			18,988				21,134
Goodwill			34,237				34,237
Deferred contract costs and other non-current assets			7,283				8,864
Total assets		$	245,013			$	260,841
Liabilities, redeemable preferred stock and stockholders' deficit
Current liabilities:
Accounts payable		$	5,298			$	10,565
Accrued expenses			17,546				9,451
Accrued compensation and benefits			11,557				16,411
Deferred revenue, current portion			27,808				27,756
Lease liabilities and financing obligations, current portion			6,387				7,378
Contingent consideration			–				675
Total current liabilities			68,596				72,236
Deferred revenue, net of current portion			2,464				2,377
Convertible senior notes			119,962				107,281
Lease liabilities and financing obligations, net current portion			74,184				75,758
Other non-current liabilities			372				313
Total liabilities			265,578				257,965
Commitments and contingencies
Redeemable preferred stock:
Series A preferred stock, par value $0.001, 5,000,000 shares   authorized, 1,777,778 and 1,777,778 shares issued and outstanding   at June 30, 2022 and December 31, 2021, respectively,   liquidation preference $45 per share as of June 30, 2022 and December 31, 2021,   respectively			79,193				79,193
Stockholders' deficit:
Common stock, par value $0.001, 95,000,000 shares authorized,   34,172,079 and 33,460,545 issued and outstanding at June 30, 2022 and December   31, 2021, respectively			34				33
Additional paid-in capital			382,204				431,874
Accumulated deficit			(481,996	)			(508,224	)
Total stockholders' deficit			(99,758	)			(76,317	)
Total liabilities, redeemable preferred stock and stockholders' deficit		$	245,013			$	260,841

Benefitfocus, Inc. Unaudited Consolidated Statements of Cash Flows (in thousands)
		Six Months Ended June 30,
		2022				2021
Cash flows from operating activities
Net loss		$	(14,441	)		$	(17,117	)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization			13,462				12,525
Stock-based compensation expense			6,504				5,899
Accretion of interest on convertible senior notes			377				5,780
Interest accrual on finance lease liabilities			22				3,244
Rent expense less than payments			(54	)			(27	)
Change in fair value of contingently returnable assets			(719	)			–
Non-cash accretion income from investments			29				506
Impairment or loss on disposal of right-of-use assets and property and equipment			1,769				4,048
Changes in operating assets and liabilities:
Accounts receivable, net			(5,851	)			1,354
Accrued interest on investments			284				(101	)
Contract, prepaid and other current assets			4,016				2,410
Deferred costs and other non-current assets			1,582				1,249
Accounts payable and accrued expenses			(6,025	)			3,520
Accrued compensation and benefits			(4,853	)			(4,907	)
Deferred revenue			139				(615	)
Other non-current liabilities			60				159
Net cash (used in) provided by operating activities			(3,699	)			17,927
Cash flows from investing activities
Purchases of investments held-to-maturity			–				(48,427	)
Proceeds from short-term investments held-to-maturity			–				48,000
Maturities of investments available-for-sale			22,045				–
Sales of investments available-for-sale			14,691				–
Business combination, net of cash acquired			(500	)			–
Purchases of property and equipment			(3,911	)			(4,483	)
Net cash provided by (used in) investing activities			32,325				(4,910	)
Cash flows from financing activities
Payments of preferred dividends			(3,200	)			(3,200	)
Payments of contingent consideration			(675	)			–
Proceeds from exercises of stock options and ESPP			–				322
Payments on financing obligations			(2	)			(224	)
Payments of principal on finance lease liabilities			(4,253	)			(2,559	)
Net cash used in financing activities			(8,130	)			(5,661	)
Net increase in cash and cash equivalents			20,496				7,356
Cash and cash equivalents, beginning of period			31,001				90,706
Cash and cash equivalents, end of period		$	51,497			$	98,062
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases in accounts payable and accrued expenses		$	52			$	–

Benefitfocus, Inc. Unaudited Reconciliation of GAAP to Non-GAAP Measures (in thousands, except share and per share data)
		Three Months Ended June 30,								Six Months Ended June 30,
		2022				2021				2022				2021
Reconciliation from Gross Profit to Non-GAAP Gross Profit:
Gross profit		$	27,492			$	32,874			$	58,831			$	69,344
Amortization of acquired intangible assets			610				336				1,232				673
Stock-based compensation expense			1,008				638				1,204				964
Total net adjustments			1,618				974				2,436				1,637
Non-GAAP gross profit		$	29,110			$	33,848			$	61,267			$	70,981
Reconciliation from Operating Loss to Non-GAAP Operating Income:
Operating loss		$	(9,967	)		$	(9,451	)		$	(10,004	)		$	(5,966	)
Amortization of acquired intangible assets			1,073				569				2,146				1,137
Stock-based compensation expense			5,315				4,376				6,504				5,899
Transaction and acquisition-related costs expensed			13				6				96				160
Impairment of lease right-of-use assets			1,769				4,003				1,769				4,003
Change in fair value of contingently returnable consideration			(719	)			—				(719	)			—
Costs not core to our business			2,800				1,717				4,755				3,598
Total net adjustments			10,251				10,671				14,551				14,797
Non-GAAP operating income		$	284			$	1,220			$	4,547			$	8,831
Reconciliation from Net Loss to Adjusted EBITDA:
Net loss		$	(12,164	)		$	(15,020	)		$	(14,441	)		$	(17,117	)
Depreciation			3,264				3,444				6,498				7,067
Amortization of software development costs			2,388				2,159				4,818				4,321
Amortization of acquired intangible assets			1,073				569				2,146				1,137
Interest income			(72	)			(54	)			(84	)			(111	)
Interest expense			2,476				5,646				4,958				11,201
Income tax expense			29				41				45				83
Stock-based compensation expense			5,315				4,376				6,504				5,899
Transaction and acquisition-related costs expensed			13				6				96				160
Impairment of lease right-of-use assets			1,769				4,003				1,769				4,003
Change in fair value of contingently returnable consideration			(719	)			—				(719	)			—
Restructuring costs			—				2,727				1,006				4,127
Costs not core to our business			2,800				1,717				4,755				3,598
Total net adjustments			18,336				24,634				31,792				41,485
Adjusted EBITDA		$	6,172			$	9,614			$	17,351			$	24,368
Reconciliation from Net Loss to Non-GAAP Net (Loss) Income:
Net loss		$	(12,164	)		$	(15,020	)		$	(14,441	)		$	(17,117	)
Amortization of acquired intangible assets			1,073				569				2,146				1,137
Stock-based compensation expense			5,315				4,376				6,504				5,899
Transaction and acquisition-related costs expensed			13				6				96				160
Impairment of lease right-of-use assets			1,769				4,003				1,769				4,003
Change in fair value of contingently returnable consideration			(719	)			—				(719	)			—
Costs not core to our business			2,800				1,717				4,755				3,598
Total net adjustments			10,251				10,671				14,551				14,797
Non-GAAP net (loss) income		$	(1,913	)		$	(4,349	)		$	110			$	(2,320	)
Calculation of Non-GAAP Earnings Per Share:
Non-GAAP net (loss) income		$	(1,913	)		$	(4,349	)		$	110			$	(2,320	)
Preferred dividends			(1,600	)			(1,600	)			(3,200	)			(3,200	)
Non-GAAP net loss available to common stockholders		$	(3,513	)		$	(5,949	)		$	(3,090	)		$	(5,520	)
Weighted average shares outstanding - basic and diluted			34,028,422				33,080,257				33,764,103				32,787,162
Shares used in computing non-GAAP net loss per share - basic and diluted			34,028,422				33,080,257				33,764,103				32,787,162
Non-GAAP net loss per common share - basic and diluted		$	(0.10	)		$	(0.18	)		$	(0.09	)		$	(0.17	)
Reconciliation of Cash Flows from Operations to Free Cash Flow:
Net cash and cash equivalents (used in) provided by operating activities		$	(699	)		$	9,163			$	(3,699	)		$	17,927
Purchases of property and equipment			(1,901	)			(2,590	)			(3,911	)			(4,483	)
Cash paid for restructuring costs			518				5				1,304				1,384
Total net adjustments			(1,383	)			(2,585	)			(2,607	)			(3,099	)
Free Cash Flow		$	(2,082	)		$	6,578			$	(6,306	)		$	14,828

FAQ

What were Benefitfocus' Q2 2022 earnings results?

Benefitfocus reported Q2 2022 revenue of $56.6 million and a GAAP net loss of $13.8 million.

What is the revenue outlook for Benefitfocus in Q3 2022?

Benefitfocus expects Q3 2022 total revenue to be between $55 million and $57 million.

How did Benefitfocus perform compared to guidance in Q2 2022?

Benefitfocus achieved revenue and adjusted EBITDA at the high end of its guidance range for Q2 2022.

What is the full-year revenue guidance for Benefitfocus in 2022?

The full-year revenue guidance for Benefitfocus in 2022 is expected to be between $252 million and $258 million.